Edition:
United States

Summit Therapeutics PLC (SMMT.OQ)

SMMT.OQ on NASDAQ Stock Exchange Global Market

2.17USD
18 Jul 2018
Change (% chg)

$-0.03 (-1.36%)
Prev Close
$2.20
Open
$2.17
Day's High
$2.23
Day's Low
$2.17
Volume
14,518
Avg. Vol
19,619
52-wk High
$16.59
52-wk Low
$2.17

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 213.33 32.89
P/E High - Last 5 Yrs. -- 284.48 47.09
P/E Low - Last 5 Yrs. -- 97.01 24.93
Beta -- 0.77 0.81
Price to Sales (TTM) -- 248.72 8.00
Price to Book (MRQ) -- 20.99 4.21
Price to Tangible Book (MRQ) -- 27.14 5.98
Price to Cash Flow (TTM) -- 127.00 22.15
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.27 -6.28
Payout Ratio(TTM) -- 83.72 47.05

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.71 4.78
Sales (TTM) vs TTM 1 Yr. Ago -- 147.36 12.03
Sales - 5 Yr. Growth Rate -- 30.70 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -78.08 46.97
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 46.73 8.00
Capital Spending - 5 Yr. Growth Rate -- 42.51 7.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.56
Current Ratio (MRQ) -- 6.62 3.63
LT Debt to Equity (MRQ) -- 24.41 13.26
Total Debt to Equity (MRQ) -- 28.60 17.41
Interest Coverage (TTM) -- -155.28 35.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.99 55.24
Gross Margin - 5 Yr. Avg. -- 53.44 53.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -181.72 15.63
Operating Margin (TTM) -- -949.33 -0.49
Operating Margin - 5 Yr. Avg. -- -195.36 10.78
Pre-Tax Margin (TTM) -- -844.82 1.31
Pre-Tax Margin - 5 Yr. Avg. -- -199.82 10.91
Net Profit Margin (TTM) -- -836.11 -1.97
Net Profit Margin - 5 Yr. Avg. -- -197.51 7.27
Effective Tax Rate (TTM) -- 14.81 20.76
Effective Tax Rate - 5 Yr. Avg. -- 19.06 24.28

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,353,109 735,028,818
Net Income/Employee (TTM) -- -792,586 85,698,805
Receivable Turnover (TTM) -- 17.81 5.95
Inventory Turnover (TTM) -- 2.86 3.72
Asset Turnover (TTM) -- 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -2.25 10.33
Return on Assets - 5 Yr. Avg. -- 2.92 11.01
Return on Investment (TTM) -- -3.69 13.14
Return on Investment - 5 Yr. Avg. -- 2.72 14.23
Return on Equity (TTM) -- -5.73 15.15
Return on Equity - 5 Yr. Avg. -- -4.45 15.58

Performance for Summit Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.